---
title: "Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | TVTX Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286157454.md"
description: "Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | TVTX Stock News"
datetime: "2026-05-12T13:00:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286157454.md)
  - [en](https://longbridge.com/en/news/286157454.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286157454.md)
---

# Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | TVTX Stock News

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | TVTX Stock News

### Related Stocks

- [TVTX.US](https://longbridge.com/en/quote/TVTX.US.md)
- [NDAQ.US](https://longbridge.com/en/quote/NDAQ.US.md)

## Related News & Research

- [Travere’s US$525 Million Convertible Refi Might Change The Case For Investing In Travere Therapeutics (TVTX)](https://longbridge.com/en/news/286451880.md)
- [Travere Therapeutics Issues New Convertible Notes to Refinance Debt](https://longbridge.com/en/news/286004504.md)
- [Travere Therapeutics (NASDAQ:TVTX) Insider Sells $13,668.45 in Stock](https://longbridge.com/en/news/285472720.md)
- [Travere Therapeutics (NASDAQ:TVTX) Posts Quarterly Earnings Results, Beats Estimates By $999.24 EPS](https://longbridge.com/en/news/285114233.md)
- [Travere Therapeutics Analysts Increase Their Forecasts Following Q1 Earnings](https://longbridge.com/en/news/285250845.md)